{"id":692,"date":"2020-05-08T01:08:59","date_gmt":"2020-05-08T01:08:59","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=692"},"modified":"2023-08-29T18:02:06","modified_gmt":"2023-08-29T18:02:06","slug":"cynata-therapeutics-cymerus-approval-clinical-trial-covid-19","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=692","title":{"rendered":"Cynata Therapeutics\u516c\u53f8\u83b7\u5f97\u4e86\u51a0\u72b6\u75c5\u6bd2\u4e34\u5e8a\u8bd5\u9a8c\u7684\u6279\u51c6"},"content":{"rendered":"<p>\u751f\u7269\u6280\u672f\u516c\u53f8<a href=\"http:\/\/smallcaps-production.test\/stocks\/?symbol=CYP&amp;lang=cn\">Cynata Therapeutics (ASX: CYP)<\/a>\u6253\u7b97\u901a\u8fc7\u91cd\u65b0\u5229\u7528\u5176Cymerus\u95f4\u5145\u8d28\u5e72\u7ec6\u80de(MSCs)\u4ea7\u54c1\u548c\u7814\u7a76\u6765\u5f00\u53d1\u51a0\u72b6\u75c5\u6bd2\u7684\u6cbb\u7597\u65b9\u6cd5\u3002<\/p>\n<p>Cynata\u5728\u5411\u5e02\u573a\u53d1\u5e03\u7684\u4e00\u4efd\u58f0\u660e\u4e2d\u8868\u793a\uff0c\u8be5\u516c\u53f8\u5df2\u83b7\u5f97\u4f26\u7406\u59d4\u5458\u4f1a\u7684\u6279\u51c6\uff0c\u5c06\u5728\u6fb3\u5927\u5229\u4e9a\u5f00\u5c55\u4e00\u9879\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4ee5\u8c03\u67e5Cymerus MSCs\u5bf9\u63a5\u53d7\u51a0\u72b6\u75c5\u6bd2\u91cd\u75c7\u76d1\u62a4\u7684\u6210\u4eba\u7684\u65e9\u671f\u7597\u6548\u3002<\/p>\n<p>\u65b0\u7684MEND(MEseNchymal coviD-19)\u8bd5\u9a8c\u5c06\u5728\u65b0\u5357\u5a01\u5c14\u58eb\u5dde\u7684\u4e2d\u5fc3\u4e0e\u5927\u8111\u6027\u762b\u75ea\u7814\u7a76\u6240\u548c\u51a0\u72b6\u75c5\u6bd2\u5e72\u7ec6\u80de\u6cbb\u7597(CSCT)\u5c0f\u7ec4\u7684\u7814\u7a76\u4eba\u5458\u5408\u4f5c\u8fdb\u884c\u3002<\/p>\n<p>\u636eCynata\u8bf4\uff0c\u8fd9\u9879\u7814\u7a76\u5c06\u662f\u4e00\u9879\u5f00\u653e\u6807\u7b7e\u3001\u968f\u673a\u5bf9\u7167\u7684\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4ee5\u8c03\u67e524\u540d\u56e0\u51a0\u72b6\u75c5\u6bd2\u548c\u547c\u5438\u7a98\u8feb\u800c\u63a5\u53d7\u91cd\u75c7\u76d1\u62a4\u7684\u6210\u5e74\u60a3\u8005\u7684Cymerus MSCs\u7684\u65e9\u671f\u7597\u6548\u3002<\/p>\n<p>\u9664\u62a4\u7406\u6807\u51c6\u5916\uff0c\u5c06\u968f\u673a\u62bd\u53d612\u540d\u60a3\u8005\u63a5\u53d7Cymerus MSC\u704c\u6ce8\uff0c\u540c\u65f6\u5c0612\u540d\u60a3\u8005\u968f\u673a\u62bd\u53d6\u5230\u5bf9\u7167\u7ec4\uff0c\u5e76\u63a5\u53d7\u76ee\u524d\u7684\u62a4\u7406\u6807\u51c6\u3002<\/p>\n<p>\u8be5\u516c\u53f8\u9996\u5e2d\u6267\u884c\u5b98\u517c\u8463\u4e8b\u603b\u7ecf\u7406Ross Macdonald\u535a\u58eb\u79f0\u8fd9\u4e00\u8fdb\u5c55\u4e3a\u201c\u91cd\u5927\u91cc\u7a0b\u7891\u201d\u3002<\/p>\n<p>\u4ed6\u8bf4:\u201c\u6211\u4eec\u6709\u5173\u75be\u75c5\u6a21\u578b\u7684\u5927\u91cf\u4e34\u5e8a\u524d\u6570\u636e\u5e93\uff0c\u4ee5\u53ca\u5bf9\u66f4\u6709\u6548\u6cbb\u7597\u51a0\u72b6\u75c5\u6bd2\u5371\u91cd\u75c7\u60a3\u8005\u7684\u8feb\u5207\u9700\u8981\uff0c\u4f7f\u6211\u4eec\u80fd\u591f\u52a0\u5feb\u89c4\u5212\u5e76\u8fc5\u901f\u83b7\u5f97\u4f26\u7406\u59d4\u5458\u4f1a\u7684\u6279\u51c6\u3002\u201d<\/p>\n<p>\u201c\u8fd9\u9879\u8bd5\u9a8c\u662f\u6211\u4eec\u7684Cymerus MSC\u4ea7\u54c1\u5728\u5176\u4ed6\u56fd\u5bb6\u51a0\u72b6\u75c5\u6bd2\u60a3\u8005\u4e2d\u8bd5\u9a8c\u7684\u66f4\u5e7f\u6cdb\u4e34\u5e8a\u53d1\u5c55\u6218\u7565\u7684\u4e00\u90e8\u5206\u3002\u201d<\/p>\n<p>Macdonald\u535a\u58eb\u8bf4:\u201c\u57fa\u4e8e\u76ee\u524d\u7684\u5168\u7403\u73af\u5883\u548c\u4e16\u536b\u7ec4\u7ec7\u5728\u547c\u5438\u7cfb\u7edf\u548c\u76f8\u5173\u75be\u75c5\u65b9\u9762\u575a\u5b9e\u7684\u4e34\u5e8a\u524d\u57fa\u7840\uff0c\u6211\u4eec\u51b3\u5b9a\u628a\u91cd\u70b9\u653e\u5728\u8fd9\u4e2a\u65b0\u7684\u4e34\u5e8a\u5f00\u53d1\u9886\u57df\uff0c\u8fd9\u662f\u5408\u4e4e\u903b\u8f91\u548c\u5ba1\u614e\u7684\u4e00\u6b65\u3002\u201d<\/p>\n<p>Cynata\u8fd8\u8868\u793a\uff0c\u5b83\u7684Cymerus\u6280\u672f\u5df2\u7ecf\u5728\u51e0\u79cd\u53ef\u80fd\u5bfc\u81f4\u4e25\u91cd\u7684\u51a0\u72b6\u75c5\u6bd29\u611f\u67d3\u548c\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81(ARDS)\u7684\u60c5\u51b5\u4e0b\u201c\u5c55\u793a\u4e86\u6709\u5e0c\u671b\u7684\u4e34\u5e8a\u524d\u8bd5\u9a8c\u7ed3\u679c\u201d\u3002<\/p>\n<p>ARDS\u662f\u4e00\u79cd\u708e\u75c7\u8fc7\u7a0b\uff0c\u53ef\u5bfc\u81f4\u80ba\u90e8\u79ef\u6db2\u548c\u547c\u5438\u8870\u7aed\uff0c\u53ef\u56e0\u611f\u67d3\u3001\u521b\u4f24\u548c\u5438\u5165\u6709\u6bd2\u7269\u8d28\u800c\u53d1\u751f\uff0c\u8fd9\u662f\u5371\u53ca\u751f\u547d\u7684COVID-19\u6700\u5e38\u89c1\u7684\u5e76\u53d1\u75c7\u4e4b\u4e00\u3002<\/p>\n<p>\u201cMEND\u8bd5\u9a8c\u5c06\u5efa\u7acb\u5728Cynata\u5728ARDS\u3001\u8113\u6bd2\u75c7\u548c\u7ec6\u80de\u56e0\u5b50\u91ca\u653e\u7efc\u5408\u5f81\u65b9\u9762\u7684\u5f3a\u5927\u7684\u4e34\u5e8a\u524d\u7814\u7a76\u6210\u679c\u7684\u57fa\u7840\u4e0a\uff0c\u6240\u6709\u8fd9\u4e9b\u90fd\u662f\u4e25\u91cd\u7684\u65b0\u51a0\u75c5\u4f8b\u7684\u5e38\u89c1\u7279\u5f81\uff0c\u201d\u8be5\u516c\u53f8\u8bf4\u3002<\/p>\n<h2>\u5728\u5176\u4ed6\u65b9\u9762<\/h2>\n<p>\u9664\u4e86\u5f00\u53d1\u6f5c\u5728\u6cbb\u7597\u51a0\u72b6\u75c5\u6bd2\u7684\u65b9\u6cd5\u5916\uff0cCynata\u8fd8\u53d1\u5e03\u4e86\u6709\u5173\u5176\u73b0\u6709\u4e34\u5e8a\u9879\u76ee\u548c\u836f\u7269\u7ba1\u9053\u7684\u6700\u65b0\u60c5\u51b5\u3002<\/p>\n<p>\u76ee\u524d\uff0c\u8be5\u516c\u53f8\u6b63\u51c6\u5907\u4e0eFUJIFILM\u516c\u53f8\u5408\u4f5c\u5f00\u5c55CYP-001\u7684\u4e34\u5e8a\u8bd5\u9a8c\uff0cCYP-001\u662f\u6cbb\u7597\u79fb\u690d\u7269\u6297\u5bbf\u4e3b\u75c5(GvHD)\u7684Cymerus\u4ea7\u54c1\u3002<\/p>\n<p>\u7136\u800c\uff0cCynata\u627f\u8ba4\u51a0\u72b6\u75c5\u6bd2\u5bf9\u516c\u53f8\u8fd0\u8425\u7684\u5f71\u54cd\u662f\u663e\u8457\u7684\u3002\u5c3d\u7ba1\u4e34\u5e8a\u8bd5\u9a8c\u62db\u52df\u9650\u5236\u4ecd\u7136\u5b58\u5728\uff0c\u4f46\u5176\u9aa8\u6027\u5173\u8282\u708e(OA)\u548c\u4e25\u91cd\u80a2\u4f53\u7f3a\u8840(CLI) 2\u671f\u8bd5\u9a8c\u7684\u542f\u52a8\u6d3b\u52a8\u4ecd\u5728\u7ee7\u7eed\u3002<\/p>\n<p>\u6089\u5c3c\u5927\u5b66\u4eba\u4f53\u7814\u7a76\u4f26\u7406\u59d4\u5458\u4f1a\u5df2\u7ecf\u5bf9\u4e8c\u671fOA\u8bd5\u9a8c\u8fdb\u884c\u4e86\u5ba1\u67e5\uff0c\u5e76\u5728\u5ba1\u67e5\u4e86\u67d0\u4e9b\u989d\u5916\u4fe1\u606f\u540e\uff0c\u539f\u5219\u4e0a\u6279\u51c6\u4e86\u8be5\u8bd5\u9a8c\uff0c\u9884\u8ba1\u6700\u7ec8\u6279\u51c6\u5c06\u5728\u201c\u4e0d\u4e45\u7684\u5c06\u6765\u201d\u8fdb\u884c\uff0cCynata\u8bf4\u3002<\/p>\n<p>\u4e0e\u6b64\u540c\u65f6\uff0c\u4eca\u5e741\u6708\u7531\u82f1\u56fd\u836f\u54c1\u548c\u4fdd\u5065\u4ea7\u54c1\u76d1\u7ba1\u5c40(MHRA)\u6279\u51c6\u7684\u7b2c\u4e8c\u9636\u6bb5CLI\u8bd5\u9a8c\uff0c\u4e5f\u5728\u6fb3\u5927\u5229\u4e9a\u5f97\u5230\u4e86\u58a8\u5c14\u672c\u536b\u751f\u4eba\u529b\u8d44\u6e90\u59d4\u5458\u4f1a\u7684\u6279\u51c6\u3002<\/p>\n<p>\u7136\u800c\uff0c\u51a0\u72b6\u75c5\u6bd2\u7684\u5f71\u54cd\u9884\u8ba1\u5c06\u6270\u4e71\u8bd5\u9a8c\uff0c\u5e76\u5728\u5f88\u957f\u4e00\u6bb5\u65f6\u95f4\u5185\u5bf9\u6f5c\u5728\u7684\u62db\u52df\u4ea7\u751f\u6301\u7eed\u5f71\u54cd\uff0c\u56e0\u4e3aCLI\u60a3\u8005\u7531\u4e8e\u5176\u5e74\u9f84\u548c\u57fa\u672c\u533b\u7597\u6761\u4ef6\uff0c\u6781\u6709\u53ef\u80fd\u51fa\u73b0\u51a0\u72b6\u75c5\u6bd2\u7684\u4e25\u91cd\u5e76\u53d1\u75c7\u3002<\/p>\n<p>Cynata\u8bf4\uff0c\u5728\u8fd9\u79cd\u60c5\u51b5\u4e0b\uff0c\u5373\u4f7f\u653e\u5bbd\u4e86\u66f4\u666e\u904d\u7684\u9650\u5236\uff0c\u4e5f\u4e0d\u80fd\u8f7b\u7387\u5730\u5f00\u59cb\u62db\u8058\u3002<\/p>\n<p>\u56e0\u6b64\uff0c\u8fd9\u5bb6\u751f\u7269\u5236\u836f\u516c\u53f8\u8868\u793a\uff0c\u5b83\u51b3\u5b9a\u91cd\u65b0\u8c03\u6574\u5176\u8d22\u52a1\u548c\u8fd0\u8425\u8d44\u6e90\uff0c\u5c06\u91cd\u70b9\u653e\u5728\u51a0\u72b6\u75c5\u6bd2\u548cARDS\u7684\u5f00\u53d1\u6218\u7565\u4e0a\uff0c\u4ee5\u52a0\u5feb\u4e34\u5e8a\u5f00\u53d1\u548c\u5b9e\u73b0\u6f5c\u5728\u4ef7\u503c\u7684\u50ac\u5316\u5242\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u751f\u7269\u6280\u672f\u516c\u53f8Cynata Therapeutics (ASX: CYP)\u6253\u7b97\u901a\u8fc7\u91cd\u65b0\u5229\u7528\u5176Cymerus\u95f4\u5145\u8d28\u5e72\u7ec6\u80de(MSCs)\u4ea7\u54c1\u548c\u7814\u7a76\u6765\u5f00\u53d1\u51a0\u72b6\u75c5\u6bd2\u7684\u6cbb\u7597\u65b9\u6cd5\u3002 Cynata\u5728\u5411\u5e02\u573a\u53d1\u5e03\u7684\u4e00\u4efd\u58f0\u660e\u4e2d\u8868\u793a\uff0c\u8be5\u516c\u53f8\u5df2\u83b7\u5f97\u4f26\u7406\u59d4\u5458\u4f1a\u7684\u6279\u51c6\uff0c\u5c06\u5728\u6fb3\u5927\u5229\u4e9a\u5f00\u5c55\u4e00\u9879\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4ee5\u8c03\u67e5Cymerus MSCs\u5bf9\u63a5\u53d7\u51a0\u72b6\u75c5\u6bd2\u91cd\u75c7\u76d1\u62a4\u7684\u6210\u4eba\u7684\u65e9\u671f\u7597\u6548\u3002 \u65b0\u7684MEND(MEseNchymal coviD-19)\u8bd5\u9a8c\u5c06\u5728\u65b0\u5357\u5a01\u5c14\u58eb\u5dde\u7684\u4e2d\u5fc3\u4e0e\u5927\u8111\u6027\u762b\u75ea\u7814\u7a76\u6240\u548c\u51a0\u72b6\u75c5\u6bd2\u5e72\u7ec6\u80de\u6cbb\u7597(CSCT)\u5c0f\u7ec4\u7684\u7814\u7a76\u4eba\u5458\u5408\u4f5c\u8fdb\u884c\u3002 \u636eCynata\u8bf4\uff0c\u8fd9\u9879\u7814\u7a76\u5c06\u662f\u4e00\u9879\u5f00\u653e\u6807\u7b7e\u3001\u968f\u673a\u5bf9\u7167\u7684\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4ee5\u8c03\u67e524\u540d\u56e0\u51a0\u72b6\u75c5\u6bd2\u548c\u547c\u5438\u7a98\u8feb\u800c\u63a5\u53d7\u91cd\u75c7\u76d1\u62a4\u7684\u6210\u5e74\u60a3\u8005\u7684Cymerus MSCs\u7684\u65e9\u671f\u7597\u6548\u3002 \u9664\u62a4\u7406\u6807\u51c6\u5916\uff0c\u5c06\u968f\u673a\u62bd\u53d612\u540d\u60a3\u8005\u63a5\u53d7Cymerus MSC\u704c\u6ce8\uff0c\u540c\u65f6\u5c0612\u540d\u60a3\u8005\u968f\u673a\u62bd\u53d6\u5230\u5bf9\u7167\u7ec4\uff0c\u5e76\u63a5\u53d7\u76ee\u524d\u7684\u62a4\u7406\u6807\u51c6\u3002 \u8be5\u516c\u53f8\u9996\u5e2d\u6267\u884c\u5b98\u517c\u8463\u4e8b\u603b\u7ecf\u7406Ross Macdonald\u535a\u58eb\u79f0\u8fd9\u4e00\u8fdb\u5c55\u4e3a\u201c\u91cd\u5927\u91cc\u7a0b\u7891\u201d\u3002 \u4ed6\u8bf4:\u201c\u6211\u4eec\u6709\u5173\u75be\u75c5\u6a21\u578b\u7684\u5927\u91cf\u4e34\u5e8a\u524d\u6570\u636e\u5e93\uff0c\u4ee5\u53ca\u5bf9\u66f4\u6709\u6548\u6cbb\u7597\u51a0\u72b6\u75c5\u6bd2\u5371\u91cd\u75c7\u60a3\u8005\u7684\u8feb\u5207\u9700\u8981\uff0c\u4f7f\u6211\u4eec\u80fd\u591f\u52a0\u5feb\u89c4\u5212\u5e76\u8fc5\u901f\u83b7\u5f97\u4f26\u7406\u59d4\u5458\u4f1a\u7684\u6279\u51c6\u3002\u201d \u201c\u8fd9\u9879\u8bd5\u9a8c\u662f\u6211\u4eec\u7684Cymerus MSC\u4ea7\u54c1\u5728\u5176\u4ed6\u56fd\u5bb6\u51a0\u72b6\u75c5\u6bd2\u60a3\u8005\u4e2d\u8bd5\u9a8c\u7684\u66f4\u5e7f\u6cdb\u4e34\u5e8a\u53d1\u5c55\u6218\u7565\u7684\u4e00\u90e8\u5206\u3002\u201d Macdonald\u535a\u58eb\u8bf4:\u201c\u57fa\u4e8e\u76ee\u524d\u7684\u5168\u7403\u73af\u5883\u548c\u4e16\u536b\u7ec4\u7ec7\u5728\u547c\u5438\u7cfb\u7edf\u548c\u76f8\u5173\u75be\u75c5\u65b9\u9762\u575a\u5b9e\u7684\u4e34\u5e8a\u524d\u57fa\u7840\uff0c\u6211\u4eec\u51b3\u5b9a\u628a\u91cd\u70b9\u653e\u5728\u8fd9\u4e2a\u65b0\u7684\u4e34\u5e8a\u5f00\u53d1\u9886\u57df\uff0c\u8fd9\u662f\u5408\u4e4e\u903b\u8f91\u548c\u5ba1\u614e\u7684\u4e00\u6b65\u3002\u201d Cynata\u8fd8\u8868\u793a\uff0c\u5b83\u7684Cymerus\u6280\u672f\u5df2\u7ecf\u5728\u51e0\u79cd\u53ef\u80fd\u5bfc\u81f4\u4e25\u91cd\u7684\u51a0\u72b6\u75c5\u6bd29\u611f\u67d3\u548c\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81(ARDS)\u7684\u60c5\u51b5\u4e0b\u201c\u5c55\u793a\u4e86\u6709\u5e0c\u671b\u7684\u4e34\u5e8a\u524d\u8bd5\u9a8c\u7ed3\u679c\u201d\u3002 ARDS\u662f\u4e00\u79cd\u708e\u75c7\u8fc7\u7a0b\uff0c\u53ef\u5bfc\u81f4\u80ba\u90e8\u79ef\u6db2\u548c\u547c\u5438\u8870\u7aed\uff0c\u53ef\u56e0\u611f\u67d3\u3001\u521b\u4f24\u548c\u5438\u5165\u6709\u6bd2\u7269\u8d28\u800c\u53d1\u751f\uff0c\u8fd9\u662f\u5371\u53ca\u751f\u547d\u7684COVID-19\u6700\u5e38\u89c1\u7684\u5e76\u53d1\u75c7\u4e4b\u4e00\u3002 \u201cMEND\u8bd5\u9a8c\u5c06\u5efa\u7acb\u5728Cynata\u5728ARDS\u3001\u8113\u6bd2\u75c7\u548c\u7ec6\u80de\u56e0\u5b50\u91ca\u653e\u7efc\u5408\u5f81\u65b9\u9762\u7684\u5f3a\u5927\u7684\u4e34\u5e8a\u524d\u7814\u7a76\u6210\u679c\u7684\u57fa\u7840\u4e0a\uff0c\u6240\u6709\u8fd9\u4e9b\u90fd\u662f\u4e25\u91cd\u7684\u65b0\u51a0\u75c5\u4f8b\u7684\u5e38\u89c1\u7279\u5f81\uff0c\u201d\u8be5\u516c\u53f8\u8bf4\u3002 \u5728\u5176\u4ed6\u65b9\u9762 \u9664\u4e86\u5f00\u53d1\u6f5c\u5728\u6cbb\u7597\u51a0\u72b6\u75c5\u6bd2\u7684\u65b9\u6cd5\u5916\uff0cCynata\u8fd8\u53d1\u5e03\u4e86\u6709\u5173\u5176\u73b0\u6709\u4e34\u5e8a\u9879\u76ee\u548c\u836f\u7269\u7ba1\u9053\u7684\u6700\u65b0\u60c5\u51b5\u3002 \u76ee\u524d\uff0c\u8be5\u516c\u53f8\u6b63\u51c6\u5907\u4e0eFUJIFILM\u516c\u53f8\u5408\u4f5c\u5f00\u5c55CYP-001\u7684\u4e34\u5e8a\u8bd5\u9a8c\uff0cCYP-001\u662f\u6cbb\u7597\u79fb\u690d\u7269\u6297\u5bbf\u4e3b\u75c5(GvHD)\u7684Cymerus\u4ea7\u54c1\u3002 \u7136\u800c\uff0cCynata\u627f\u8ba4\u51a0\u72b6\u75c5\u6bd2\u5bf9\u516c\u53f8\u8fd0\u8425\u7684\u5f71\u54cd\u662f\u663e\u8457\u7684\u3002\u5c3d\u7ba1\u4e34\u5e8a\u8bd5\u9a8c\u62db\u52df\u9650\u5236\u4ecd\u7136\u5b58\u5728\uff0c\u4f46\u5176\u9aa8\u6027\u5173\u8282\u708e(OA)\u548c\u4e25\u91cd\u80a2\u4f53\u7f3a\u8840(CLI) 2\u671f\u8bd5\u9a8c\u7684\u542f\u52a8\u6d3b\u52a8\u4ecd\u5728\u7ee7\u7eed\u3002 \u6089\u5c3c\u5927\u5b66\u4eba\u4f53\u7814\u7a76\u4f26\u7406\u59d4\u5458\u4f1a\u5df2\u7ecf\u5bf9\u4e8c\u671fOA\u8bd5\u9a8c\u8fdb\u884c\u4e86\u5ba1\u67e5\uff0c\u5e76\u5728\u5ba1\u67e5\u4e86\u67d0\u4e9b\u989d\u5916\u4fe1\u606f\u540e\uff0c\u539f\u5219\u4e0a\u6279\u51c6\u4e86\u8be5\u8bd5\u9a8c\uff0c\u9884\u8ba1\u6700\u7ec8\u6279\u51c6\u5c06\u5728\u201c\u4e0d\u4e45\u7684\u5c06\u6765\u201d\u8fdb\u884c\uff0cCynata\u8bf4\u3002 \u4e0e\u6b64\u540c\u65f6\uff0c\u4eca\u5e741\u6708\u7531\u82f1\u56fd\u836f\u54c1\u548c\u4fdd\u5065\u4ea7\u54c1\u76d1\u7ba1\u5c40(MHRA)\u6279\u51c6\u7684\u7b2c\u4e8c\u9636\u6bb5CLI\u8bd5\u9a8c\uff0c\u4e5f\u5728\u6fb3\u5927\u5229\u4e9a\u5f97\u5230\u4e86\u58a8\u5c14\u672c\u536b\u751f\u4eba\u529b\u8d44\u6e90\u59d4\u5458\u4f1a\u7684\u6279\u51c6\u3002 \u7136\u800c\uff0c\u51a0\u72b6\u75c5\u6bd2\u7684\u5f71\u54cd\u9884\u8ba1\u5c06\u6270\u4e71\u8bd5\u9a8c\uff0c\u5e76\u5728\u5f88\u957f\u4e00\u6bb5\u65f6\u95f4\u5185\u5bf9\u6f5c\u5728\u7684\u62db\u52df\u4ea7\u751f\u6301\u7eed\u5f71\u54cd\uff0c\u56e0\u4e3aCLI\u60a3\u8005\u7531\u4e8e\u5176\u5e74\u9f84\u548c\u57fa\u672c\u533b\u7597\u6761\u4ef6\uff0c\u6781\u6709\u53ef\u80fd\u51fa\u73b0\u51a0\u72b6\u75c5\u6bd2\u7684\u4e25\u91cd\u5e76\u53d1\u75c7\u3002 Cynata\u8bf4\uff0c\u5728\u8fd9\u79cd\u60c5\u51b5\u4e0b\uff0c\u5373\u4f7f\u653e\u5bbd\u4e86\u66f4\u666e\u904d\u7684\u9650\u5236\uff0c\u4e5f\u4e0d\u80fd\u8f7b\u7387\u5730\u5f00\u59cb\u62db\u8058\u3002 \u56e0\u6b64\uff0c\u8fd9\u5bb6\u751f\u7269\u5236\u836f\u516c\u53f8\u8868\u793a\uff0c\u5b83\u51b3\u5b9a\u91cd\u65b0\u8c03\u6574\u5176\u8d22\u52a1\u548c\u8fd0\u8425\u8d44\u6e90\uff0c\u5c06\u91cd\u70b9\u653e\u5728\u51a0\u72b6\u75c5\u6bd2\u548cARDS\u7684\u5f00\u53d1\u6218\u7565\u4e0a\uff0c\u4ee5\u52a0\u5feb\u4e34\u5e8a\u5f00\u53d1\u548c\u5b9e\u73b0\u6f5c\u5728\u4ef7\u503c\u7684\u50ac\u5316\u5242\u3002<\/p>\n","protected":false},"author":5,"featured_media":693,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[230],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Cynata Therapeutics\u516c\u53f8\u83b7\u5f97\u4e86\u51a0\u72b6\u75c5\u6bd2\u4e34\u5e8a\u8bd5\u9a8c\u7684\u6279\u51c6<\/title>\n<meta name=\"description\" content=\"\u751f\u7269\u6280\u672f\u516c\u53f8Cynata Therapeutics (ASX: CYP)\u6253\u7b97\u901a\u8fc7\u91cd\u65b0\u5229\u7528\u5176Cymerus\u95f4\u5145\u8d28\u5e72\u7ec6\u80de(MSCs)\u4ea7\u54c1\u548c\u7814\u7a76\u6765\u5f00\u53d1\u51a0\u72b6\u75c5\u6bd2\u7684\u6cbb\u7597\u65b9\u6cd5\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cynata Therapeutics\u516c\u53f8\u83b7\u5f97\u4e86\u51a0\u72b6\u75c5\u6bd2\u4e34\u5e8a\u8bd5\u9a8c\u7684\u6279\u51c6\" \/>\n<meta property=\"og:description\" content=\"\u751f\u7269\u6280\u672f\u516c\u53f8Cynata Therapeutics (ASX: CYP)\u6253\u7b97\u901a\u8fc7\u91cd\u65b0\u5229\u7528\u5176Cymerus\u95f4\u5145\u8d28\u5e72\u7ec6\u80de(MSCs)\u4ea7\u54c1\u548c\u7814\u7a76\u6765\u5f00\u53d1\u51a0\u72b6\u75c5\u6bd2\u7684\u6cbb\u7597\u65b9\u6cd5\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/cynata-therapeutics-cymerus-approval-clinical-trial-covid-19\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2020-05-08T01:08:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T18:02:06+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/05\/Cynata-Therapeutics-ASX-CYP-clinical-trial-COVID-19-ethics-approval-Cymerus-mesenchymal-stem-cells-MSCs.jpg\" \/>\n<meta name=\"author\" content=\"Small Caps\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Cynata Therapeutics\u516c\u53f8\u83b7\u5f97\u4e86\u51a0\u72b6\u75c5\u6bd2\u4e34\u5e8a\u8bd5\u9a8c\u7684\u6279\u51c6\" \/>\n<meta name=\"twitter:description\" content=\"\u751f\u7269\u6280\u672f\u516c\u53f8Cynata Therapeutics (ASX: CYP)\u6253\u7b97\u901a\u8fc7\u91cd\u65b0\u5229\u7528\u5176Cymerus\u95f4\u5145\u8d28\u5e72\u7ec6\u80de(MSCs)\u4ea7\u54c1\u548c\u7814\u7a76\u6765\u5f00\u53d1\u51a0\u72b6\u75c5\u6bd2\u7684\u6cbb\u7597\u65b9\u6cd5\u3002\" \/>\n<meta name=\"twitter:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/05\/Cynata-Therapeutics-ASX-CYP-clinical-trial-COVID-19-ethics-approval-Cymerus-mesenchymal-stem-cells-MSCs.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Small Caps\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/cynata-therapeutics-cymerus-approval-clinical-trial-covid-19\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/cynata-therapeutics-cymerus-approval-clinical-trial-covid-19\/\",\"name\":\"Cynata Therapeutics\u516c\u53f8\u83b7\u5f97\u4e86\u51a0\u72b6\u75c5\u6bd2\u4e34\u5e8a\u8bd5\u9a8c\u7684\u6279\u51c6\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2020-05-08T01:08:59+00:00\",\"dateModified\":\"2023-08-29T18:02:06+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\"},\"description\":\"\u751f\u7269\u6280\u672f\u516c\u53f8Cynata Therapeutics (ASX: CYP)\u6253\u7b97\u901a\u8fc7\u91cd\u65b0\u5229\u7528\u5176Cymerus\u95f4\u5145\u8d28\u5e72\u7ec6\u80de(MSCs)\u4ea7\u54c1\u548c\u7814\u7a76\u6765\u5f00\u53d1\u51a0\u72b6\u75c5\u6bd2\u7684\u6cbb\u7597\u65b9\u6cd5\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/cynata-therapeutics-cymerus-approval-clinical-trial-covid-19\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/cynata-therapeutics-cymerus-approval-clinical-trial-covid-19\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/cynata-therapeutics-cymerus-approval-clinical-trial-covid-19\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cynata Therapeutics\u516c\u53f8\u83b7\u5f97\u4e86\u51a0\u72b6\u75c5\u6bd2\u4e34\u5e8a\u8bd5\u9a8c\u7684\u6279\u51c6\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\",\"name\":\"Small Caps\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"caption\":\"Small Caps\"},\"description\":\"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=5\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Cynata Therapeutics\u516c\u53f8\u83b7\u5f97\u4e86\u51a0\u72b6\u75c5\u6bd2\u4e34\u5e8a\u8bd5\u9a8c\u7684\u6279\u51c6","description":"\u751f\u7269\u6280\u672f\u516c\u53f8Cynata Therapeutics (ASX: CYP)\u6253\u7b97\u901a\u8fc7\u91cd\u65b0\u5229\u7528\u5176Cymerus\u95f4\u5145\u8d28\u5e72\u7ec6\u80de(MSCs)\u4ea7\u54c1\u548c\u7814\u7a76\u6765\u5f00\u53d1\u51a0\u72b6\u75c5\u6bd2\u7684\u6cbb\u7597\u65b9\u6cd5\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Cynata Therapeutics\u516c\u53f8\u83b7\u5f97\u4e86\u51a0\u72b6\u75c5\u6bd2\u4e34\u5e8a\u8bd5\u9a8c\u7684\u6279\u51c6","og_description":"\u751f\u7269\u6280\u672f\u516c\u53f8Cynata Therapeutics (ASX: CYP)\u6253\u7b97\u901a\u8fc7\u91cd\u65b0\u5229\u7528\u5176Cymerus\u95f4\u5145\u8d28\u5e72\u7ec6\u80de(MSCs)\u4ea7\u54c1\u548c\u7814\u7a76\u6765\u5f00\u53d1\u51a0\u72b6\u75c5\u6bd2\u7684\u6cbb\u7597\u65b9\u6cd5\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/cynata-therapeutics-cymerus-approval-clinical-trial-covid-19\/","og_site_name":"smallcapsCN","article_published_time":"2020-05-08T01:08:59+00:00","article_modified_time":"2023-08-29T18:02:06+00:00","og_image":[{"url":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/05\/Cynata-Therapeutics-ASX-CYP-clinical-trial-COVID-19-ethics-approval-Cymerus-mesenchymal-stem-cells-MSCs.jpg"}],"author":"Small Caps","twitter_card":"summary_large_image","twitter_title":"Cynata Therapeutics\u516c\u53f8\u83b7\u5f97\u4e86\u51a0\u72b6\u75c5\u6bd2\u4e34\u5e8a\u8bd5\u9a8c\u7684\u6279\u51c6","twitter_description":"\u751f\u7269\u6280\u672f\u516c\u53f8Cynata Therapeutics (ASX: CYP)\u6253\u7b97\u901a\u8fc7\u91cd\u65b0\u5229\u7528\u5176Cymerus\u95f4\u5145\u8d28\u5e72\u7ec6\u80de(MSCs)\u4ea7\u54c1\u548c\u7814\u7a76\u6765\u5f00\u53d1\u51a0\u72b6\u75c5\u6bd2\u7684\u6cbb\u7597\u65b9\u6cd5\u3002","twitter_image":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/05\/Cynata-Therapeutics-ASX-CYP-clinical-trial-COVID-19-ethics-approval-Cymerus-mesenchymal-stem-cells-MSCs.jpg","twitter_misc":{"Written by":"Small Caps"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/cynata-therapeutics-cymerus-approval-clinical-trial-covid-19\/","url":"https:\/\/smallcapscn.x5view.co\/cynata-therapeutics-cymerus-approval-clinical-trial-covid-19\/","name":"Cynata Therapeutics\u516c\u53f8\u83b7\u5f97\u4e86\u51a0\u72b6\u75c5\u6bd2\u4e34\u5e8a\u8bd5\u9a8c\u7684\u6279\u51c6","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2020-05-08T01:08:59+00:00","dateModified":"2023-08-29T18:02:06+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74"},"description":"\u751f\u7269\u6280\u672f\u516c\u53f8Cynata Therapeutics (ASX: CYP)\u6253\u7b97\u901a\u8fc7\u91cd\u65b0\u5229\u7528\u5176Cymerus\u95f4\u5145\u8d28\u5e72\u7ec6\u80de(MSCs)\u4ea7\u54c1\u548c\u7814\u7a76\u6765\u5f00\u53d1\u51a0\u72b6\u75c5\u6bd2\u7684\u6cbb\u7597\u65b9\u6cd5\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/cynata-therapeutics-cymerus-approval-clinical-trial-covid-19\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/cynata-therapeutics-cymerus-approval-clinical-trial-covid-19\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/cynata-therapeutics-cymerus-approval-clinical-trial-covid-19\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Cynata Therapeutics\u516c\u53f8\u83b7\u5f97\u4e86\u51a0\u72b6\u75c5\u6bd2\u4e34\u5e8a\u8bd5\u9a8c\u7684\u6279\u51c6"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74","name":"Small Caps","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","caption":"Small Caps"},"description":"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.","url":"https:\/\/smallcapscn.x5view.co\/?author=5"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/692"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=692"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/692\/revisions"}],"predecessor-version":[{"id":7787,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/692\/revisions\/7787"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/693"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=692"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=692"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=692"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}